Thursday, July 24, 2025
1:00PM – 2:00PM ET
Please note this virtual program is 1:00PM Eastern, 12:00PM Central, 11:00AM Mountain and 10:00AM Pacific.
FACULTY
 |
Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES Assistant Professor of Medicine Case Western Reserve University Program Director Diabetes Technology Diabetes and Metabolic Care Center University Hospitals Cleveland, Ohio |
PROGRAM OVERVIEW
This series focuses on enhancing clinicians’ ability to identify and manage early-stage type 1 diabetes (T1D) in high-risk patients. Participants will learn to apply screening criteria, interpret results, and communicate effectively with patients to guide timely treatment decisions. The program emphasizes building referral pathways and fostering collaboration with specialists to enable earlier use of disease-modifying therapies. Learners will also explore evidence-based criteria for selecting appropriate candidates for these therapies and implementing protocols to ensure their safe and efficient administration.
TARGET AUDIENCE
This activity is designed to meet the educational needs of multidisciplinary clinicians who refer, treat, or see patients with, or at high risk for, T1D, including primary care clinicians, pediatricians, pediatric and adult endocrinologists, diabetes educators, nurses, infusion professionals, and other allied healthcare professionals.
LEARNING OBJECTIVES
Upon the completion of this program, learners should be better able to:
- Identify criteria for T1D screening, focusing on high-risk patients to facilitate timely referral and monitoring
- Interpret T1D screening results and effectively communicate next steps to support patient education and inform treatment decisions.
- Develop strategies for establishing referral pathways and enhancing collaboration with specialists in order to enable earlier application of disease-modifying therapies for early stage T1D.
- Identify appropriate patients who would benefit from treatment with disease-modifying therapies for delaying T1D progression based on clinical evidence
- Implement protocols to support safe and efficient administration of disease-modifying therapies for T1D according to guidance and patient-specific factors.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 CPEU.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
